Cargando…
Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice
AIMS/HYPOTHESIS: Transcription factor 7-like 2 (TCF7L2) is a downstream effector of the Wnt/β-catenin signalling pathway implicated in type 2 diabetes risk through genome-wide association studies. Although its expression is critical for adipocyte development, the potential roles of changes in adipos...
Autores principales: | Nguyen-Tu, Marie-Sophie, Martinez-Sanchez, Aida, Leclerc, Isabelle, Rutter, Guy A., da Silva Xavier, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567653/ https://www.ncbi.nlm.nih.gov/pubmed/33068125 http://dx.doi.org/10.1007/s00125-020-05292-4 |
Ejemplares similares
-
Targeted deletion of Tcf7l2 in adipocytes promotes adipocyte hypertrophy and impaired glucose metabolism
por: Geoghegan, Gisela, et al.
Publicado: (2019) -
Transcription factor-7–like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling, β cell growth, and insulin secretion
por: Nguyen-Tu, Marie-Sophie, et al.
Publicado: (2018) -
Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice
por: da Silva Xavier, Gabriela, et al.
Publicado: (2017) -
Adipocyte Phenotype Flexibility and Lipid Dysregulation
por: Preston, Kyle J., et al.
Publicado: (2022) -
Deletion of Trim28 in committed adipocytes promotes obesity but preserves glucose tolerance
por: Bond, Simon T., et al.
Publicado: (2021)